Analgesics
Antiandrogens
Antihistamines
Bromhexine
Budesonide
Colchicine
Conv. Plasma
Curcumin
Fluvoxamine
Hydroxychlor..
Ivermectin
Lifestyle
Melatonin
Metformin
Minerals
Monoclonals
Mpro inhibitors
Naso/orophar..
Nigella Sativa
Nitazoxanide
PPIs
Quercetin
RdRp inhibitors
Thermotherapy
Vitamins
More

Other
Feedback
Home
 
next
study
previous
study
c19early.org COVID-19 treatment researchVitamin DVitamin D (more..)
Metformin Meta
Bromhexine Meta
Budesonide Meta
Colchicine Meta Nigella Sativa Meta
Conv. Plasma Meta Nitazoxanide Meta
Curcumin Meta PPIs Meta
Fluvoxamine Meta Quercetin Meta
Hydroxychlor.. Meta
Ivermectin Meta Thermotherapy Meta
Melatonin Meta

All Studies   Meta Analysis       

A Study on Serum Vitamin D3 Level in Patients with Covid-19: A Cross-Sectional Study in Kolkata

Hossain et al., National Journal of Medical Research, doi:10.55489/njmr.150220251070
Apr 2025  
  Post
  Facebook
Share
  Source   PDF   All Studies   Meta AnalysisMeta
Severe case 58% Improvement Relative Risk Vitamin D for COVID-19  Hossain et al.  Sufficiency Are vitamin D levels associated with COVID-19 outcomes? Retrospective 100 patients in India (January 2021 - January 2022) Lower severe cases with higher vitamin D levels (p=0.0015) c19early.org Hossain et al., National J. Medical Re.., Apr 2025 Favorsvitamin D Favorscontrol 0 0.5 1 1.5 2+
Vitamin D for COVID-19
8th treatment shown to reduce risk in October 2020, now with p < 0.00000000001 from 125 studies, recognized in 18 countries.
No treatment is 100% effective. Protocols combine treatments.
5,500+ studies for 120 treatments. c19early.org
Analysis of 100 hospitalized COVID-19 patients in India showing strong association between vitamin D deficiency and COVID-19 severity.
This is the 216th COVID-19 sufficiency study for vitamin D, which collectively show higher levels reduce risk with p<0.0000000001 (1 in 27,502,236,897 vigintillion).
risk of severe case, 58.4% lower, RR 0.42, p = 0.002, high D levels (≥20 ng/ml) 8 of 33 (24.2%), low D levels (<20 ng/ml) 39 of 67 (58.2%), NNT 2.9.
Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates
Hossain et al., 1 Apr 2025, retrospective, India, peer-reviewed, mean age 51.7, 5 authors, study period January 2021 - January 2022. Contact: amritajha.1102@gmail.com.
This PaperVitamin DAll
A Study on Serum Vitamin D3 Level in Patients with Covid-19: A Cross-Sectional Study in Kolkata
Enamul Hossain, Sanjay K Mandal, Souvik Sarkar, Amrita Jha, Ranjan Mondal
National Journal of Medical Research, doi:10.55489/njmr.150220251070
Background: Coronavirus disease (COVID-19) is a global pandemic caused by SARS-CoV-2. Vitamin D has immunomodulatory and anti-inflammatory properties, potentially influencing the disease course. This study assessed the prevalence of 25(OH) vitamin D deficiency in COVID-19 patients and its association with disease severity in the Indian population. Methodology: A hospital-based cross-sectional study was conducted at Medical College, Kolkata, including 100 RT-PCR-confirmed moderate and severe COVID-19 patients. Disease severity was categorized based on oxygen saturation. Serum 25-Hydroxy vitamin D levels were measured on admission, along with other hematological and biochemical parameters. High-resolution CT scans were performed to assess pulmonary involvement. Results: Vitamin D insufficiency and deficiency were observed in 18% and 67% of patients, respectively. Deficiency was more prevalent in severe cases (82.97%) than moderate cases (52.83%). The mean vitamin D levels in moderate and severe disease groups were 23.23±8.74 and 17.17±8.09 ng/ml, respectively. A significant association was found between vitamin D deficiency and COVID-19 severity (P = 0.006). The vitamin D cutoff for predicting severe disease was 18.57 ng/dl. Conclusion: Vitamin D deficiency is strongly associated with severe COVID-19 in the Indian population. Low vitamin D levels may predict disease severity, suggesting supplementation as a potential preventive strategy.
Conflict of Interest: The authors have declared that no conflicts of interest exist.
References
Cereda, Bogliolo, Klersy, Vitamin D 25OH deficiency in COVID-19 patients admitted to a tertiary referral hospital, Clinical nutrition, doi:10.1016/j.clnu.2020.10.055PMid:33187772PMCid
Chan, Rout, Use of neutrophil-to-lymphocyte and platelet-tolymphocyte ratios in COVID-19, Journal of clinical medicine research, doi:10.14740/jocmr4240PMid:32655740PMCid:PMC7331861
Chan, Rout, Use of neutrophil-to-lymphocyte and platelet-tolymphocyte ratios in COVID-19, Journal of clinical medicine research, doi:10.14740/jocmr4240PMid:32655740PMCid:PMC7331861
Cheng, Luo, Wang, Kidney impairment is associated with in-hospital death of COVID-19 patients, MedRxiv, doi:10.1101/2020.02.18.20023242
Cheng, Luo, Wang, Kidney impairment is associated with in-hospital death of COVID-19 patients, MedRxiv, doi:10.1101/2020.02.18.20023242
Francone, Iafrate, Masci, Chest CT score in COVID-19 patients: correlation with disease severity and short-term prognosis, European radiology, doi:10.1007/s00330-020-07033-yPMid:32623505
Ginde, Mansbach, Camargo, Vitamin D, respiratory infections, and asthma. Current allergy and asthma reports, doi:10.1007/s11882-009-0012-7
Hamming, Timens, Bulthuis, Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis, J Pathol, doi:10.1002/path.1570PMid:15141377
Jain, Chaurasia, Sengar, Singh, Mahor et al., Analysis of vitamin D level among asymptomatic and critically ill COVID-19 patients and its correlation with inflammatory markers, Scientific reports, doi:10.1038/s41598-020-77093-zPMid:33214648PMCid:PMC7677378
Lemire, Adams, Sakai, Jordan, 1 alpha, 25-dihydroxyvitamin D3 suppresses proliferation and immunoglobulin production by normal human peripheral blood mononuclear cells, The Journal of clinical investigation, doi:10.1172/JCI111465PMid:6611355PMCid:PMC370520
Li, Ye, Chen, Elevated Lactate Dehydrogenase (LDH) level as an independent risk factor for the severity and mortality of COVID-19, Aging, doi:10.18632/aging.103770PMid:32805722
Li, Ye, Chen, Elevated Lactate Dehydrogenase (LDH) level as an independent risk factor for the severity and mortality of COVID-19, Aging, doi:10.18632/aging.103770PMid:32805722
Lin, Long, Yang, Chen, Xu et al., Serum ferritin as an independent risk factor for severity in COVID-19 patients, Journal of infection, doi:10.1016/j.jinf.2020.06.053PMid:32592705PMCid
Lin, Long, Yang, Chen, Xu et al., Serum ferritin as an independent risk factor for severity in COVID-19 patients, Journal of infection, doi:10.1016/j.jinf.2020.06.053PMid:32592705PMCid
Luo, Liao, Shen, Li, Cheng, Vitamin D deficiency is associated with COVID-19 incidence and disease severity in Chinese people, The Journal of nutrition, doi:10.1093/jn/nxaa332PMid:33188401
Nimavat, Singh, Singh, Singh, Sinha, Vitamin D deficiency and COVID-19: A case-control study at a tertiary care hospital in India, Annals of Medicine and Surgery, doi:10.1016/j.amsu.2021.102661PMid:34377451
Prietl, Treiber, Pieber, Amrein, Vitamin D and immune function, Nutrients, doi:10.3390/nu5072502PMid:23857223PMCid:PMC3738984
Radujkovic, Hippchen, Tiwari-Heckler, Vitamin D deficiency and outcome of COVID-19 patients, Nutrients, doi:10.3390/nu12092757
Smet, Smet, Herroelen, Gryspeerdt, Martens, Serum 25 (OH) D level on hospital admission associated with COVID-19 stage and mortality, American journal of clinical pathology, doi:10.1093/ajcp/aqaa252PMid:33236114PMCid:PMC7717135
Teama, Abdelhakam, Elmohamadi, Badr, Vitamin D deficiency as a predictor of severity in patients with COVID-19 infection, Science Progress, doi:10.1177/00368504211036854
Teama, Abdelhakam, Elmohamadi, Badr, Vitamin D deficiency as a predictor of severity in patients with COVID-19 infection, Science Progress, doi:10.1177/00368504211036854PMid:34347528PMCid:PMC10450705
Wang, Hu, Hu, Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China, JAMA, doi:10.1001/jama.2020.1585PMid:32031570PMCid:PMC7042881
Wang, Shi, Wang, Duan, Yang, Albumin and total bilirubin for severity and mortality in coronavirus disease 2019 patients, Journal of Clinical Laboratory Analysis, doi:10.1002/jcla.23412PMid:32745325PMCid:PMC7323086
Wang, Shi, Wang, Duan, Yang, Albumin and total bilirubin for severity and mortality in coronavirus disease 2019 patients, Journal of Clinical Laboratory Analysis, doi:10.1002/jcla.23412PMid:32745325PMCid:PMC7323086
Yang, Liu, Liu, COVID-19: immunopathogenesis and Immunotherapeutics, Signal transduction and targeted therapy, doi:10.1038/s41392-020-00243-2PMid:32712629PMCid:PMC7381863
Yao, Cao, Wang, Shi, Liu et al., D-dimer as a biomarker for disease severity and mortality in COVID-19 patients: a case control study, Journal of intensive care, doi:10.1186/s40560-020-00466-zPMid:32665858PMCid:PMC7348129
Yao, Cao, Wang, Shi, Liu et al., D-dimer as a biomarker for disease severity and mortality in COVID-19 patients: a case control study, Journal of intensive care, doi:10.1186/s40560-020-00466-zPMid:32665858PMCid:PMC7348129
Ye, Tang, Liao, Does serum vitamin D level affect COVID-19 infection and its severity? -A case-control study, Journal of the American College of Nutrition, doi:10.1080/07315724.2020.1826005PMid:33048028
DOI record: { "DOI": "10.55489/njmr.150220251070", "ISSN": [ "2277-8810", "2249-4995" ], "URL": "http://dx.doi.org/10.55489/njmr.150220251070", "abstract": "<jats:p>Background: Coronavirus disease (COVID-19) is a global pandemic caused by SARS-CoV-2. Vitamin D has immunomodulatory and anti-inflammatory properties, potentially influencing the disease course. This study assessed the prevalence of 25(OH) vitamin D deficiency in COVID-19 patients and its association with disease severity in the Indian population.\nMethodology: A hospital-based cross-sectional study was conducted at Medical College, Kolkata, including 100 RT-PCR-confirmed moderate and severe COVID-19 patients. Disease severity was categorized based on oxygen saturation. Serum 25-Hydroxy vitamin D levels were measured on admission, along with other hematological and biochemical parameters. High-resolution CT scans were performed to assess pulmonary involvement.\nResults: Vitamin D insufficiency and deficiency were observed in 18% and 67% of patients, respectively. Deficiency was more prevalent in severe cases (82.97%) than moderate cases (52.83%). The mean vitamin D levels in moderate and severe disease groups were 23.23±8.74 and 17.17±8.09 ng/ml, respectively. A significant association was found between vitamin D deficiency and COVID-19 severity (P = 0.006). The vitamin D cutoff for predicting severe disease was 18.57 ng/dl.\nConclusion: Vitamin D deficiency is strongly associated with severe COVID-19 in the Indian population. Low vitamin D levels may predict disease severity, suggesting supplementation as a potential preventive strategy.</jats:p>", "author": [ { "ORCID": "https://orcid.org/0000-0002-6283-1665", "affiliation": [], "authenticated-orcid": false, "family": "Hossain", "given": "Enamul", "sequence": "first" }, { "ORCID": "https://orcid.org/0000-0002-2925-056X", "affiliation": [], "authenticated-orcid": false, "family": "Mandal", "given": "Sanjay K", "sequence": "additional" }, { "ORCID": "https://orcid.org/0000-0002-0662-6333", "affiliation": [], "authenticated-orcid": false, "family": "Sarkar", "given": "Souvik", "sequence": "additional" }, { "ORCID": "https://orcid.org/0009-0001-8331-8131", "affiliation": [], "authenticated-orcid": false, "family": "Jha", "given": "Amrita", "sequence": "additional" }, { "ORCID": "https://orcid.org/0009-0001-4207-5233", "affiliation": [], "authenticated-orcid": false, "family": "Mondal", "given": "Ranjan", "sequence": "additional" } ], "container-title": "National Journal of Medical Research", "container-title-short": "Natl J Med Res", "content-domain": { "crossmark-restriction": false, "domain": [] }, "created": { "date-parts": [ [ 2025, 4, 1 ] ], "date-time": "2025-04-01T10:28:11Z", "timestamp": 1743503291000 }, "deposited": { "date-parts": [ [ 2025, 4, 1 ] ], "date-time": "2025-04-01T10:36:49Z", "timestamp": 1743503809000 }, "indexed": { "date-parts": [ [ 2025, 4, 1 ] ], "date-time": "2025-04-01T11:10:08Z", "timestamp": 1743505808339, "version": "3.40.3" }, "is-referenced-by-count": 0, "issue": "02", "issued": { "date-parts": [ [ 2025, 4, 1 ] ] }, "journal-issue": { "issue": "02", "published-online": { "date-parts": [ [ 2025, 4, 1 ] ] } }, "license": [ { "URL": "https://creativecommons.org/licenses/by-sa/4.0", "content-version": "unspecified", "delay-in-days": 0, "start": { "date-parts": [ [ 2025, 4, 1 ] ], "date-time": "2025-04-01T00:00:00Z", "timestamp": 1743465600000 } } ], "link": [ { "URL": "https://njmr.in/index.php/file/article/download/1070/890", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining" }, { "URL": "https://njmr.in/index.php/file/article/download/1070/890", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking" } ], "member": "34154", "original-title": [], "page": "126-131", "prefix": "10.55489", "published": { "date-parts": [ [ 2025, 4, 1 ] ] }, "published-online": { "date-parts": [ [ 2025, 4, 1 ] ] }, "publisher": "Medsci Publications", "reference": [ { "DOI": "10.1002/path.1570", "doi-asserted-by": "crossref", "key": "3875", "unstructured": "Hamming I, Timens W, Bulthuis ML, et al. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J Pathol. 2004;203(2):631-637. DOI: https://doi.org/10.1002/path.1570 PMid:15141377 PMCid:PMC7167720" }, { "DOI": "10.1001/jama.2020.1585", "doi-asserted-by": "crossref", "key": "3876", "unstructured": "Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020;323(11):1061. DOI: https://doi.org/10.1001/jama.2020.1585 PMid:32031570 PMCid:PMC7042881" }, { "DOI": "10.1038/s41392-020-00243-2", "doi-asserted-by": "crossref", "key": "3877", "unstructured": "Yang L, Liu S, Liu J, et al. COVID-19: immunopathogenesis and Immunotherapeutics. Signal transduction and targeted therapy. 2020 Jul 25;5(1):1-8. DOI: https://doi.org/10.1038/s41392-020-00243-2 PMid:32712629 PMCid:PMC7381863" }, { "DOI": "10.3390/nu5072502", "doi-asserted-by": "crossref", "key": "3878", "unstructured": "Prietl B, Treiber G, Pieber TR, Amrein K. Vitamin D and immune function. Nutrients. 2013 Jul 5;5(7):2502-21. DOI: https://doi.org/10.3390/nu5072502 PMid:23857223 PMCid:PMC3738984" }, { "DOI": "10.1172/JCI111465", "doi-asserted-by": "crossref", "key": "3879", "unstructured": "Lemire JM, Adams JS, Sakai R, Jordan SC. 1 alpha, 25-dihydroxyvitamin D3 suppresses proliferation and immunoglobulin production by normal human peripheral blood mononuclear cells. The Journal of clinical investigation. 1984 Aug 1;74(2):657-61. DOI: https://doi.org/10.1172/JCI111465 PMid:6611355 PMCid:PMC370520" }, { "DOI": "10.1007/s11882-009-0012-7", "doi-asserted-by": "crossref", "key": "3880", "unstructured": "Ginde AA, Mansbach JM, Camargo CA. Vitamin D, respiratory infections, and asthma. Current allergy and asthma reports. 2009 Jan;9(1):81-7. DOI: https://doi.org/10.1007/s11882-009-0012-7 PMid:19063829" }, { "DOI": "10.1016/j.amsu.2021.102661", "doi-asserted-by": "crossref", "key": "3881", "unstructured": "Nimavat N, Singh S, Singh P, Singh SK, Sinha N. Vitamin D deficiency and COVID-19: A case-control study at a tertiary care hospital in India. Annals of Medicine and Surgery. 2021 Aug 1;68:102661. DOI: https://doi.org/10.1016/j.amsu.2021.102661 PMid:34377451 PMCid:PMC8339450" }, { "DOI": "10.1038/s41598-020-77093-z", "doi-asserted-by": "crossref", "key": "3882", "unstructured": "Jain A, Chaurasia R, Sengar NS, Singh M, Mahor S, Narain S. Analysis of vitamin D level among asymptomatic and critically ill COVID-19 patients and its correlation with inflammatory markers. Scientific reports. 2020 Nov 19;10(1):1-8. DOI: https://doi.org/10.1038/s41598-020-77093-z PMid:33214648 PMCid:PMC7677378" }, { "DOI": "10.1093/jn/nxaa332", "doi-asserted-by": "crossref", "key": "3883", "unstructured": "Luo X, Liao Q, Shen Y, Li H, Cheng L. Vitamin D deficiency is associated with COVID-19 incidence and disease severity in Chinese people. The Journal of nutrition. 2021 Jan;151(1):98-103. DOI: https://doi.org/10.1093/jn/nxaa332 PMid:33188401 PMCid:PMC7890671" }, { "DOI": "10.3390/nu12092757", "doi-asserted-by": "crossref", "key": "3884", "unstructured": "Radujkovic A, Hippchen T, Tiwari-Heckler S, et al. Vitamin D deficiency and outcome of COVID-19 patients. Nutrients. 2020 Sep 10;12(9):2757. DOI: https://doi.org/10.3390/nu12092757 PMid:32927735 PMCid:PMC7551780" }, { "DOI": "10.1080/07315724.2020.1826005", "doi-asserted-by": "crossref", "key": "3885", "unstructured": "Ye K, Tang F, Liao X, et al. Does serum vitamin D level affect COVID-19 infection and its severity? -A case-control study. Journal of the American College of Nutrition. 2021 Nov 10;40(8):724-31. DOI: https://doi.org/10.1080/07315724.2020.1826005 PMid:33048028" }, { "DOI": "10.1093/ajcp/aqaa252", "doi-asserted-by": "crossref", "key": "3886", "unstructured": "De Smet D, De Smet K, Herroelen P, Gryspeerdt S, Martens GA. Serum 25 (OH) D level on hospital admission associated with COVID-19 stage and mortality. American journal of clinical pathology. 2021 Mar;155(3):381-8. DOI: https://doi.org/10.1093/ajcp/aqaa252 PMid:33236114 PMCid:PMC7717135" }, { "DOI": "10.1007/s00330-020-07033-y", "doi-asserted-by": "crossref", "key": "3887", "unstructured": "Francone M, Iafrate F, Masci GM, et al. Chest CT score in COVID-19 patients: correlation with disease severity and short-term prognosis. European radiology. 2020 Dec;30(12):6808-17. DOI: https://doi.org/10.1007/s00330-020-07033-y PMid:32623505 PMCid:PMC7334627" }, { "DOI": "10.1016/j.clnu.2020.10.055", "doi-asserted-by": "crossref", "key": "3888", "unstructured": "Cereda E, Bogliolo L, Klersy C, et al. Vitamin D 25OH deficiency in COVID-19 patients admitted to a tertiary referral hospital. Clinical nutrition. 2021 Apr 1;40(4):2469-72. DOI: https://doi.org/10.1016/j.clnu.2020.10.055 PMid:33187772 PMCid:PMC7605851" }, { "DOI": "10.1177/00368504211036854", "doi-asserted-by": "crossref", "key": "3889", "unstructured": "Teama MA, Abdelhakam DA, Elmohamadi MA, Badr FM. Vitamin D deficiency as a predictor of severity in patients with COVID-19 infection. Science Progress. 2021 Aug;104(3):00368504211036854. DOI: https://doi.org/10.1177/00368504211036854 PMid:34347528 PMCid:PMC10450705" }, { "DOI": "10.14740/jocmr4240", "doi-asserted-by": "crossref", "key": "3890", "unstructured": "Chan AS, Rout A. Use of neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios in COVID-19. Journal of clinical medicine research. 2020 Jul;12(7):448. DOI: https://doi.org/10.14740/jocmr4240 PMid:32655740 PMCid:PMC7331861" }, { "DOI": "10.1016/j.kint.2020.03.005", "doi-asserted-by": "crossref", "key": "3891", "unstructured": "Cheng Y, Luo R, Wang K, et al. Kidney impairment is associated with in-hospital death of COVID-19 patients. MedRxiv. 2020 Jan 1. DOI: https://doi.org/10.1101/2020.02.18.20023242" }, { "DOI": "10.1002/jcla.23412", "doi-asserted-by": "crossref", "key": "3892", "unstructured": "Wang Y, Shi L, Wang Y, Duan G, Yang H. Albumin and total bilirubin for severity and mortality in coronavirus disease 2019 patients. Journal of Clinical Laboratory Analysis. 2020 Jul;34(7). DOI: https://doi.org/10.1002/jcla.23412 PMid:32745325 PMCid:PMC7323086" }, { "DOI": "10.1186/s40560-020-00466-z", "doi-asserted-by": "crossref", "key": "3893", "unstructured": "Yao Y, Cao J, Wang Q, Shi Q, Liu K, Luo Z, Chen X, Chen S, Yu K, Huang Z, Hu B. D-dimer as a biomarker for disease severity and mortality in COVID-19 patients: a case control study. Journal of intensive care. 2020 Dec;8(1):1-1. DOI: https://doi.org/10.1186/s40560-020-00466-z PMid:32665858 PMCid:PMC7348129" }, { "DOI": "10.1016/j.jinf.2020.06.053", "doi-asserted-by": "crossref", "key": "3894", "unstructured": "Lin Z, Long F, Yang Y, Chen X, Xu L, Yang M. Serum ferritin as an independent risk factor for severity in COVID-19 patients. Journal of infection. 2020 Oct 1;81(4):647-79. DOI: https://doi.org/10.1016/j.jinf.2020.06.053 PMid:32592705 PMCid:PMC7313486" }, { "DOI": "10.18632/aging.103770", "doi-asserted-by": "crossref", "key": "3895", "unstructured": "Li C, Ye J, Chen Q, et al. Elevated Lactate Dehydrogenase (LDH) level as an independent risk factor for the severity and mortality of COVID-19. Aging (Albany NY). 2020 Aug 8;12(15):15670. DOI: https://doi.org/10.18632/aging.103770 PMid:32805722 PMCid:PMC7467395" }, { "DOI": "10.1016/j.clnu.2020.10.055", "doi-asserted-by": "crossref", "key": "3896", "unstructured": "a tertiary referral hospital. Clinical nutrition. 2021 Apr 1;40(4):2469-72. DOI: https://doi.org/10.1016/j.clnu.2020.10.055 PMid:33187772 PMCid:PMC7605851" }, { "DOI": "10.1177/00368504211036854", "doi-asserted-by": "crossref", "key": "3897", "unstructured": "Teama MA, Abdelhakam DA, Elmohamadi MA, Badr FM. Vitamin D deficiency as a predictor of severity in patients with COVID-19 infection. Science Progress. 2021 Aug;104(3):00368504211036854. DOI: https://doi.org/10.1177/00368504211036854 PMid:34347528 PMCid:PMC10450705" }, { "DOI": "10.14740/jocmr4240", "doi-asserted-by": "crossref", "key": "3898", "unstructured": "Chan AS, Rout A. Use of neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios in COVID-19. Journal of clinical medicine research. 2020 Jul;12(7):448. DOI: https://doi.org/10.14740/jocmr4240 PMid:32655740 PMCid:PMC7331861" }, { "DOI": "10.1016/j.kint.2020.03.005", "doi-asserted-by": "crossref", "key": "3899", "unstructured": "Cheng Y, Luo R, Wang K, et al. Kidney impairment is associated with in-hospital death of COVID-19 patients. MedRxiv. 2020 Jan 1. DOI: https://doi.org/10.1101/2020.02.18.20023242" }, { "DOI": "10.1002/jcla.23412", "doi-asserted-by": "crossref", "key": "3900", "unstructured": "Wang Y, Shi L, Wang Y, Duan G, Yang H. Albumin and total bilirubin for severity and mortality in coronavirus disease 2019 patients. Journal of Clinical Laboratory Analysis. 2020 Jul;34(7). DOI: https://doi.org/10.1002/jcla.23412 PMid:32745325 PMCid:PMC7323086" }, { "DOI": "10.1186/s40560-020-00466-z", "doi-asserted-by": "crossref", "key": "3901", "unstructured": "Yao Y, Cao J, Wang Q, Shi Q, Liu K, Luo Z, Chen X, Chen S, Yu K, Huang Z, Hu B. D-dimer as a biomarker for disease severity and mortality in COVID-19 patients: a case control study. Journal of intensive care. 2020 Dec;8(1):1-1. DOI: https://doi.org/10.1186/s40560-020-00466-z PMid:32665858 PMCid:PMC7348129" }, { "DOI": "10.1016/j.jinf.2020.06.053", "doi-asserted-by": "crossref", "key": "3902", "unstructured": "Lin Z, Long F, Yang Y, Chen X, Xu L, Yang M. Serum ferritin as an independent risk factor for severity in COVID-19 patients. Journal of infection. 2020 Oct 1;81(4):647-79. DOI: https://doi.org/10.1016/j.jinf.2020.06.053 PMid:32592705 PMCid:PMC7313486" }, { "DOI": "10.18632/aging.103770", "doi-asserted-by": "crossref", "key": "3903", "unstructured": "Li C, Ye J, Chen Q, et al. Elevated Lactate Dehydrogenase (LDH) level as an independent risk factor for the severity and mortality of COVID-19. Aging (Albany NY). 2020 Aug 8;12(15):15670. DOI: https://doi.org/10.18632/aging.103770 PMid:32805722 PMCid:PMC7467395" } ], "reference-count": 29, "references-count": 29, "relation": {}, "resource": { "primary": { "URL": "https://njmr.in/index.php/file/article/view/1070" } }, "score": 1, "short-title": [], "source": "Crossref", "subject": [], "subtitle": [], "title": "A Study on Serum Vitamin D3 Level in Patients with Covid-19: A Cross-Sectional Study in Kolkata", "type": "journal-article", "volume": "15" }
Loading..
Please send us corrections, updates, or comments. c19early involves the extraction of 100,000+ datapoints from thousands of papers. Community updates help ensure high accuracy. Treatments and other interventions are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit